Genome Guardian
Alpherior · 2024 · $11.99 · Action · deal grade C
Measured on 2026-10-05 13:38 UTC. The whole catalog is re-measured daily; a game that just launched can move fast between passes.
- Estimated net residual revenue: $126 to $189 per month
- Opportunity: $205 per month at x1.30 dormancy
- Estimated lifetime owners: 28.4k
- 92% positive across 787 reviews · 1.8 reviews/month
Why it's flagged
- Developer active, last post 7 months ago
- Studio active elsewhere (3 titles tracked), so this one may welcome a partner
- Store page localized in only 1 language(s)
- Last discounted 0 months ago, 12 sales in the last 12 months
- Proven demand elasticity: x1.5 review velocity during past deep sales
Analyst notes (AI-assisted)
Note written 2026-09-20; the live figures above take precedence over any numbers in it.
A 2024 action game built around weapon and enemy fusion mechanics, where combining elements creates emergent gameplay.
Genome Guardian sits in a narrow but profitable niche: a mechanically sound action title with strong player sentiment and a core concept that tests well. The game generates solid three-figure monthly residuals from a modest player base and has attracted nearly 800 reviews since launch, suggesting word-of-mouth durability. It is not a major IP play, but the fusion system shows design promise that could anchor a small publishing or revival push, especially if German localization and wider marketing can shrink the current loc gap. Most realistic play: publishing.
- Risk: Action genre on Steam is saturated; mainstream awareness remains very low despite positive sentiment, suggesting discoverability or positioning weakness.
- Risk: No discount promotions in the last 12 months may indicate either stable pricing strategy or lack of marketing push; upside from sales events is untested.
- Risk: Single-language release (English only) in a title with German language reviews at 6.5% gap suggests untapped regional potential but also potential localization debt.
This case as Markdown · Estimates carry ±30-50% error per title.